Resources

Colonoscopists use this form to report adverse outcomes of diagnostic investigation procedures for National Bowel Cancer Screening Program patients who have received a positive iFOBT result. Only use this form if the information has not already been included in the colonoscopy and histopathology.

This letter tells people about the National Bowel Cancer Screening Program and encourages them to participate.

People aged 50 to 74 will receive this letter in the mail, along with a bowel cancer screening test kit. This is part of the National Bowel Cancer Screening Program.

This report outlines the impact of COVID-19 on the National Bowel Cancer Screening Program. By simulating, comparing and reporting on multiple scenarios, the Cancer Council NSW have modelled and analysed potential effect of disruptions to the screening program due to COVID-19.

Service providers for the National Bowel Cancer Screening Program should use this form to nominate a bank account to the National Cancer Screening Register. Payments for notification of information provided will be made to this account.

This booklet provides information about the National Bowel Cancer Screening Program. It tells you about bowel cancer, the screening process and what happens after you get your results.

This poster shows how your body starts repairing once you stop smoking.

This fact sheet for health professionals provides information and tips on how general practices can encourage their patients to take part in the National Bowel Cancer Screening Program.

This is a sample of the form that is sent to people eligible to participate in the National Bowel Cancer Screening Program.

This flowchart shows the pathways that people take through the National Bowel Cancer Screening Program. It identifies what stages people are contacted throughout the process and who contacts them.

General practitioners (GPs) use this form to provide information about consultations with bowel cancer screening patients who have received a positive iFOBT test result.

General practitioners (GPs) use this form to provide information about consultations with bowel cancer screening patients who have received a positive iFOBT test result.

Colonoscopists use this form to report adverse outcomes of diagnostic investigation procedures for National Bowel Cancer Screening Program patients who have received a positive iFOBT result. Only use this form if the information has not already been included in the colonoscopy and histopathology.

Histopathologists use this form to report the results for specimens collected during a surgical resection procedure for a National Bowel Cancer Screening Program patient with a positive iFOBT result.

Colonoscopists use this form to report an adverse outcome for a procedure relating to diagnostic investigation of a National Bowel Cancer Screening Program participant who has received a positive iFOBT result. Only use this form if this has not already been included in the Colonoscopy Report.

Colonoscopists use this form to report an adverse outcome for a procedure relating to diagnostic investigation of a National Bowel Cancer Screening Program participant who has received a positive iFOBT result. Only use this form if this has not already been included in the Colonoscopy Report.

Histopathologists use this form to report the results for specimens collected during a surgical resection procedure for a National Bowel Cancer Screening Program patient with a positive iFOBT result.

Statement from the Standing Committee on Screening about what men need to consider before they decide to get tested for prostate cancer.

This brochure explains what a colonoscopy is and how it is done. It outlines how to prepare and what happens after the test.

This brochure provides some simple facts about bowel cancer and the National Bowel Cancer Screening Program.

People aged 73 to 74 will receive this letter in the mail, along with their final bowel cancer screening test kit. This is part of the National Bowel Cancer Screening Program.